LianBio LIANY
OTC · stock · Pharmaceutical Preparations · website · IPO 2021-10-28
LianBio statistics & valuation
Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| Return on assets | -34.5% | -46.0% | -50.0% |
| Return on equity | -37.6% | -50.7% | 105.1% |
| Current ratio | 13.24 | 26.48 | 44.45 |
Source: SEC EDGAR filings · CIK 0001831283 · US · as of 2022-12-31. facts plus Stocktoria's own computed scores — not investment advice.